Your browser doesn't support javascript.
loading
A Case of Metastatic Fumarate Hydratase-Deficient-like Renal Cell Carcinoma Successfully Managed by Ipilimumab plus Nivolumab.
Sekito, Takanori; Takamoto, Atsushi; Kobayashi, Yasuyuki; Mitsui, Masao; Watari, Shogo; Kubota, Risa; Sadahira, Takuya; Iwata, Takehiro; Nishimura, Shingo; Edamura, Kohei; Sako, Tomoko; Araki, Motoo; Watanabe, Masami; Watanabe, Toyohiko; Shibata, Rei; Ennishi, Daisuke; Nasu, Yasutomo.
Afiliação
  • Sekito T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Takamoto A; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Kobayashi Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Mitsui M; Department of Urology, Kurashiki Medical Center.
  • Watari S; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Kubota R; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Sadahira T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Iwata T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Nishimura S; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Edamura K; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Sako T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Watanabe M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Watanabe T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
  • Shibata R; Department of Pathology, Okayama University Hospital.
  • Ennishi D; Department of Hematology and Oncology, Okayama University Hospital.
  • Nasu Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
Acta Med Okayama ; 75(3): 397-402, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34176946

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article